Glass articles with mixed polymer and metal oxide coatings

A pharmaceutical package comprising:

• a glass container comprising a first surface and a second surface opposite the first surface, wherein the first surface is an outer surface of the glass container;
• and
• a coating positioned on and in direct contact with at least a portion of the first surface of the glass container, the coating comprising:
• a fluorinated polyimide copolymer formed from a dianhydride monomer component and a diamine monomer component, wherein the dianhydride monomer component is 2,2-bis(3,4-dicarboxyphenyl)hexafluoropropane dianhydride (6FDA), and the diamine monomer component is selected from the group consisting of (i) 1,4-phenylenediamine (mPDA) and 1,3-phenylenediamine (pPDA);
• (ii) 4,4′-oxydianiline (ODA);
• (iii) 4,4′-(2,2,2-trifluoro(1-trifluoromethyl)ethylidene)bisbenzeneamine (4,4′-6F);
• (iv) 3,3′-(2,2,2-trifluoro(1-trifluoromethyl)ethylidene)bisbenzeneamine (3,3′-6F);
• (v) 2,3,5,6-tetramethylphenylene;
• and (vi) 2,2,-bis[4-(4-aminophenoxy)phenyl] hexafluoropropane (4BDAF);
• and
• from 35.8 wt. % to 94.8 wt. % alumina;
• wherein:
• the fluorinated polyimide copolymer and the alumina are mixed in the coating;
• the coating has a thickness of 100 nm or less;
• the combination of the fluorinated polyimide copolymer and alumina comprise at least 99.5 wt. % of the coating;
• the portion of the first surface of the glass container with the coating has a coefficient of friction of less than or equal to about 0.5;
• and
• the portion of the first surface of the glass container with the coating retains the coefficient of friction of less than or equal to about 0.5 following a heat treatment at a temperature of at least about 300° C. for about 30 minutes.